Loading...
VM logo

Voyageur Pharmaceuticals Ltd.TSXV:VM Stock Report

Market Cap CA$28.3m
Share Price
n/a
1Y-62.1%
7D19.0%
1D0%
Portfolio Value
​
View

Voyageur Pharmaceuticals Ltd.

TSXV:VM Stock Report

Market Cap: CA$28.3m

Voyageur Pharmaceuticals (VM) Stock Overview

Engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. More details

VM fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Risk Analysis

Earnings have declined by 14.6% per year over past 5 years

Makes less than USD$1m in revenue (CA$31K)

Shareholders have been substantially diluted in the past year

Volatile share price over the past 3 months compared to the Canadian market

+ 1 more risk

VM Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Voyageur Pharmaceuticals Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Voyageur Pharmaceuticals
Historical stock prices
Current Share PriceCA$0.13
52 Week HighCA$0.34
52 Week LowCA$0.07
Beta0.34
1 Month Change47.06%
3 Month Change0%
1 Year Change-62.12%
3 Year Change78.57%
5 Year Change-3.85%
Change since IPO0%

Recent News & Updates

Recent updates

Analysis Article • Dec 18

Have Insiders Been Buying Voyageur Pharmaceuticals Ltd. (CVE:VM) Shares?

We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also...

Shareholder Returns

VMCA PharmaceuticalsCA Market
7D19.0%8.0%-0.6%
1Y-62.1%56.8%29.0%

Return vs Industry: VM underperformed the Canadian Pharmaceuticals industry which returned 51.9% over the past year.

Return vs Market: VM underperformed the Canadian Market which returned 28.9% over the past year.

Price Volatility

Is VM's price volatile compared to industry and market?
VM volatility
VM Average Weekly Movement15.0%
Pharmaceuticals Industry Average Movement10.2%
Market Average Movement9.7%
10% most volatile stocks in CA Market16.5%
10% least volatile stocks in CA Market3.7%

Stable Share Price: VM's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: VM's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
n/an/aBrent Willisvoyageurpharmaceuticals.ca

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products.

Voyageur Pharmaceuticals Ltd. Fundamentals Summary

How do Voyageur Pharmaceuticals's earnings and revenue compare to its market cap?
VM fundamental statistics
Market capCA$28.29m
Earnings (TTM)-CA$3.34m
Revenue (TTM)CA$30.96k
913.9x
P/S Ratio
-8.5x
P/E Ratio

Is VM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VM income statement (TTM)
RevenueCA$30.96k
Cost of RevenueCA$30.96k
Gross ProfitCA$0
Other ExpensesCA$3.34m
Earnings-CA$3.34m

Last Reported Earnings

Feb 28, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-0.015
Gross Margin0%
Net Profit Margin-10,796.29%
Debt/Equity Ratio6.1%

How did VM perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/30 09:55
End of Day Share Price 2026/06/30 00:00
Earnings2026/02/28
Annual Earnings2025/11/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Voyageur Pharmaceuticals Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel AppiahCapital Network by Proactive Investors